Overview of Quality by Design
Instructor:
John Avellanet
Product ID: 700862
Drawing upon FDA insights, client case studies and industry experiences, this seminar presents the basics of Quality by Design in such a way as to allow attendees to understand Quality by Design as it applies to their company and their products.
Areas Covered in the seminar:
- What is the FDA’s Quality by Design initiative?
- Why is the FDA pushing Quality by Design?
- Comparison of traditional model (from concept to post-market) to new Quality by Design model.
- Outlook for Quality by Design in the FDA, EU and IC.
- Benefits of Quality by Design.
- Success factors in adopting Quality by Design.
What will Attendee Learn:
- Firm understanding of FDA, EU and ICH expectations.
- Overview of current and emerging Quality by Design strategies.
- Be able to develop a business case (including estimated return on investment) for Quality by Design adoption.
- Understand the background and nature of best practices for Quality by Design.
Who will benefit:
- VPs, directors and senior managers of pharmaceutical, biotechnology and medical device companies
- Small to midsized company C-level executives
- Biotechnology startup management teams
- Executives in research and development (R&D), preclinical, manufacturing, regulatory affairs, and quality management
- Venture capitalists looking to speed the time to market of their funded clients
Instructor Profile:
John Avellanet, is a leading international authority on lean compliance and quality by design. He is the publisher of the monthly SMARTERCOMPLIANCE™ executive newsletter, coauthor of the book, Best Practices for Biotechnology Business Development, and a frequent speaker and radio guest. As a result of his work, Mr. Avellanet’s clients have seen faster times to market, higher product development success rates and better financial results.
For more than 15 years, he served as an executive accountable for regulatory compliance, information technology and records management, most recently as a C-level executive for a Fortune 50 biotechnology and medical device subsidiary. In 2006, he co-founded his private consulting firm, Cerulean Associates LLC (www.ceruleanllc.com).
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
